Advertisement
UK markets close in 2 hours 54 minutes
  • FTSE 100

    7,956.47
    +24.49 (+0.31%)
     
  • FTSE 250

    19,869.68
    +59.02 (+0.30%)
     
  • AIM

    743.22
    +1.11 (+0.15%)
     
  • GBP/EUR

    1.1691
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2639
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    56,280.18
    -111.05 (-0.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,247.44
    -1.05 (-0.02%)
     
  • DOW

    39,790.08
    +30.00 (+0.08%)
     
  • CRUDE OIL

    82.44
    +1.09 (+1.34%)
     
  • GOLD FUTURES

    2,230.50
    +17.80 (+0.80%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.56
    +15.47 (+0.08%)
     
  • CAC 40

    8,221.97
    +17.16 (+0.21%)
     

Invitation to Idorsia's half year financial results 2018 webcast and conference call

Date: Tuesday, July 24, 2018

Time: 14:00 CEST / 13:00 BST / 08:00 EDT

The call will start with presentations by senior management, followed by a Q&A session (live access to the speakers).

To support your preparations, the consensus estimates can be found under www.idorsia.com/consensus-estimate.

Dial-in: Participants should start calling the number below 10-15 minutes before the conference is due to start.

CH: +41 44 580 65 22 | UK: +44 203 009 2470 | US: +1 877 423 0830

PIN: 83543647#

Webcast: Participants should go to the Idorsia website www.idorsia.com 10-15 minutes before the conference is due to start.

ADVERTISEMENT

Replay: A replay of the investor webcast will be available through www.idorsia.com approximately 60 minutes after the call has ended.

Kind regards,

Andrew Weiss
Head of Investor Relations and Corporate Communications

Invitation PDF



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Idorsia Pharmaceuticals Ltd. via GlobeNewswire

HUG#2206280